Kiyoshi Yoshida Selected Research

Atherosclerosis

1/2015	Risk Factors for Progression of Degenerative Aortic Valve Disease in the Japanese- The Japanese Aortic Stenosis Study (JASS) Prospective Analysis.
9/2010	Relation between progression of aortic valve sclerosis and carotid intima-media thickening in asymptomatic subjects with cardiovascular risk factors.
6/2009	C-reactive protein predicts non-target lesion revascularization and cardiac events following percutaneous coronary intervention in patients with angina pectoris.
10/2008	C-Reactive protein predicts severity, progression, and prognosis of asymptomatic aortic valve stenosis.
3/2008	Addition of eplerenone to an angiotensin-converting enzyme inhibitor effectively improves nitric oxide bioavailability.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kiyoshi Yoshida Research Topics

Disease

9	Heart Failure 01/2019 - 01/2007
6	Atrial Fibrillation 10/2022 - 02/2006
6	Cardiovascular Diseases (Cardiovascular Disease) 12/2017 - 01/2007
6	Myocardial Ischemia (Ischemic Heart Diseases) 05/2016 - 12/2004
5	Inflammation (Inflammations) 09/2015 - 01/2007
5	Atherosclerosis 01/2015 - 03/2008
5	Thrombosis (Thrombus) 01/2014 - 07/2010
5	Myocardial Infarction 06/2008 - 12/2002
4	Fibrosis (Cirrhosis) 08/2015 - 05/2007
4	Angina Pectoris 06/2013 - 07/2004
3	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2022 - 04/2008
3	Stroke (Strokes) 01/2022 - 02/2006
3	Aortic Valve Stenosis (Aortic Stenosis) 12/2017 - 10/2008
3	Coronary Stenosis (Coronary Artery Stenosis) 03/2017 - 10/2007
3	Pathologic Constriction (Stenosis) 06/2013 - 11/2004
3	Atherosclerotic Plaque (Atheroma) 10/2010 - 10/2007
2	Hemorrhage 01/2022 - 02/2006
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2019 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 02/2002
2	Neoplasms (Cancer) 12/2018 - 07/2013
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 01/2016
2	Hyperemia 03/2017 - 01/2005
2	Unstable Angina 08/2015 - 11/2004
2	Chest Pain (Chest Pains) 09/2014 - 10/2012
2	Thrombocytopenia (Thrombopenia) 01/2014 - 01/2013
2	Hypertension (High Blood Pressure) 07/2010 - 01/2009
2	Rupture 02/2010 - 10/2007
2	Left Ventricular Dysfunction 01/2008 - 08/2005
2	Acute Coronary Syndrome 10/2007 - 05/2007
1	Mitral Valve Stenosis (Mitral Stenosis) 01/2022
1	Embolism (Embolus) 01/2022
1	Clubfoot (Talipes Equinovarus) 09/2020
1	Cerebral Palsy (Spastic Diplegia) 07/2019
1	Scoliosis 07/2019
1	Aortic Diseases 04/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2018
1	Hypertrophy 10/2018
1	Hypercholesterolemia 01/2018
1	Hypoxia (Hypoxemia) 03/2017
1	Hyponatremia 05/2016
1	Stable Angina 08/2015
1	AIDS-Related Complex (ARC) 01/2014
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2013
1	Hypersensitivity (Allergy) 07/2011
1	Obstructive Sleep Apnea 06/2011
1	Heart Diseases (Heart Disease) 07/2010
1	Heart Valve Diseases (Valvular Heart Disease) 07/2010

Drug/Important Bio-Agent (IBA)

5	Warfarin (Coumadin)FDA LinkGeneric 10/2022 - 03/2010
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 01/2007
5	LipidsIBA 01/2018 - 10/2010
5	C-Reactive ProteinIBA 08/2015 - 10/2008
3	Angiotensin Receptor AntagonistsIBA 12/2017 - 06/2008
3	Adenosine Triphosphate (ATP)IBA 03/2017 - 12/2004
2	AnticoagulantsIBA 10/2022 - 02/2006
2	Angiotensin IIIBA 03/2017 - 03/2008
2	Nicorandil (SG 75)IBA 03/2017 - 12/2004
2	DiureticsIBA 12/2016 - 01/2007
2	Sirolimus (Rapamycin)FDA Link 09/2014 - 10/2012
2	Heparin (Liquaemin)FDA LinkGeneric 01/2014 - 01/2013
2	MetalsIBA 07/2013 - 10/2012
2	Glucose (Dextrose)FDA LinkGeneric 06/2013 - 01/2002
2	EdaravoneIBA 09/2009 - 08/2007
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2008 - 01/2007
1	N(2)-(3-trifluoromethylphenyl)guanineIBA 01/2022
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 07/2019
1	LDL CholesterolIBA 01/2019
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019
1	HaptoglobinsIBA 12/2018
1	Vitamin K FDA Link 12/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2017
1	NitratesIBA 03/2017
1	Adenosine (Adenocard)FDA LinkGeneric 03/2017
1	A 7 (A-7)IBA 10/2016
1	SodiumIBA 05/2016
1	Tolvaptan FDA Link 05/2016
1	Natriuretic PeptidesIBA 11/2015
1	human NPPA protein (carperitide)IBA 11/2015
1	Phosphotransferases (Kinase)IBA 09/2015
1	Tyrosine (L-Tyrosine)FDA Link 09/2015
1	CalciumIBA 01/2014
1	omega-Chloroacetophenone (Mace)IBA 08/2013
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2013
1	Fluspirilene (Imap)IBA 02/2013
1	Contrast MediaIBA 07/2011
1	Biomarkers (Surrogate Marker)IBA 09/2010
1	Ticlopidine (Ticlid)FDA LinkGeneric 07/2010
1	Hemoglobins (Hemoglobin)IBA 03/2010

Therapy/Procedure

10	Therapeutics 01/2022 - 02/2006
9	Percutaneous Coronary Intervention 01/2016 - 12/2002
9	Stents 09/2014 - 01/2002
2	Mitral Valve Annuloplasty 01/2022 - 04/2008
2	Drug-Eluting Stents 07/2013 - 10/2012
2	Catheters 07/2004 - 09/2002
1	Tenotomy 09/2020
1	Braces 07/2019
1	Endovascular Aneurysm Repair 04/2019
1	Transcatheter Aortic Valve Replacement 10/2018
1	Continuous Positive Airway Pressure 06/2011
1	Surgical Amputation (Amputations) 02/2010
1	Cardiac Resynchronization Therapy 07/2009